The agency has sought to minimize environmental oversight, and critics say the agency also has become incentivized to cut ...
Seeking Alpha on MSN19m
Ryder System reports mixed Q4, gives underwhelming sales outlookRyder Systems (NYSE:R) reports 17% profit growth in Q4 with record earnings across segments despite freight headwinds.
Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas.
Liam Gallagher responds to Oasis fans seeing their tickets cancelled, phone users have been warned to check half-term roaming charges - and we're relaunching our Women in Business series, where we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results